摘要
Liver metastasis(LM) is one of the major causes of death in patients with colorectal cancer(CRC). Approxi-mately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presenta-tion. Surgical resection is currently the only curative treatment for patients with colorectal LM(CRLM). In recent years, with the help of modern multimodality therapy including systemic chemotherapy, radiation therapy, and surgery, the outcomes of CRLM treatment have significantly improved. This article summarizes the current status of surgical treatment of CRLM including evaluation of resectability, treatment for resectable LM, conversion therapy and liver transplantation for unresectable cases, liver resection for recurrent CRLM and elderly patients, and surgery for concomitant hepatic and extra-hepatic metastatic disease(EHMD). We believe that with the help of modern multimodality therapy, an aggressive oncosurgical approach should be implemented as it has the possibility of achieving a cure, even when EHMD is present in patients with CRLM.
Liver metastasis(LM) is one of the major causes of death in patients with colorectal cancer(CRC). Approxi-mately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presenta-tion. Surgical resection is currently the only curative treatment for patients with colorectal LM(CRLM). In recent years, with the help of modern multimodality therapy including systemic chemotherapy, radiation therapy, and surgery, the outcomes of CRLM treatment have significantly improved. This article summarizes the current status of surgical treatment of CRLM including evaluation of resectability, treatment for resectable LM, conversion therapy and liver transplantation for unresectable cases, liver resection for recurrent CRLM and elderly patients, and surgery for concomitant hepatic and extra-hepatic metastatic disease(EHMD). We believe that with the help of modern multimodality therapy, an aggressive oncosurgical approach should be implemented as it has the possibility of achieving a cure, even when EHMD is present in patients with CRLM.
引文
1 Ferlay J,Soerjomataram I,Dikshit R,Eser S,Mathers C,Rebelo M,Parkin DM,Forman D,Bray F.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN2012.Int J Cancer 2015;136:E359-E386[PMID:25220842 DOI:10.1002/ijc.29210]
2 Kemeny N.The management of resectable and unresectable liver metastases from colorectal cancer.Curr Opin Oncol 2010;22:364-373[PMID:20520544 DOI:10.1097/CCO.0b013e32833a6c8a]
3 Lupinacci RM,Andraus W,De Paiva Haddad LB,Carneiro D’Albuquerque LA,Herman P.Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases:a systematic review.Tech Coloproctol 2014;18:129-135[PMID:24057357 DOI:10.1007/s10151-013-1072-1]
4 Siegel RL,Miller KD,Jemal A.Cancer statistics,2018.CACancer J Clin 2018;68:7-30[PMID:29313949 DOI:10.3322/caac.21442]
5 Chakedis J,Squires MH,Beal EW,Hughes T,Lewis H,Paredes A,Al-Mansour M,Sun S,Cloyd JM,Pawlik TM.Update on current problems in colorectal liver metastasis.Curr Probl Surg 2017;54:554-602[PMID:29198365 DOI:10.1067/j.cpsurg.2017.10.002]
6 Line PD,Hagness M,Dueland S.The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases.Can J Gastroenterol Hepatol 2018;2018:8547940[PMID:29623266 DOI:10.1155/2018/8547940]
7 Hof J,Wertenbroek MW,Peeters PM,Widder J,Sieders E,de Jong KP.Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.Br J Surg2016;103:1055-1062[PMID:27193207 DOI:10.1002/bjs.10162]
8 Omichi K,Shindoh J,Cloyd JM,Mizuno T,Chun YS,Conrad C,Aloia TA,Tzeng CD,Vauthey JN.Liver resection is justified for patients with bilateral multiple colorectal liver metastases:Apropensity-score-matched analysis.Eur J Surg Oncol 2018;44:122-129[PMID:29208318 DOI:10.1016/j.ejso.2017.11.006]
9 Ekberg H,Tranberg KG,Andersson R,Lundstedt C,H?gerstrand I,Ranstam J,Bengmark S.Determinants of survival in liver resection for colorectal secondaries.Br J Surg 1986;73:727-731[PMID:3756436 DOI:10.1002/bjs.1800730917]
10 van Dam RM,Lodewick TM,van den Broek MA,de Jong MC,Greve JW,Jansen RL,Bemelmans MH,Neumann UP,Olde Damink SW,Dejong CH.Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.HPB(Oxford)2014;16:550-559[PMID:24246003 DOI:10.1111/hpb.12181]
11 ViganòL,Capussotti L,Majno P,Toso C,Ferrero A,De Rosa G,Rubbia-Brandt L,Mentha G.Liver resection in patients with eight or more colorectal liver metastases.Br J Surg 2015;102:92-101[PMID:25451181 DOI:10.1002/bjs.9680]
12 Allard MA,Adam R,Giuliante F,Lapointe R,Hubert C,Ijzermans JNM,Mirza DF,Elias D,Laurent C,Gruenberger T,Poston G,Letoublon C,Isoniemi H,Lucidi V,Popescu I,Figueras J.Long-term outcomes of patients with 10 or more colorectal liver metastases.Br J Cancer 2017;117:604-611[PMID:28728167DOI:10.1038/bjc.2017.218]
13 Adams RB,Aloia TA,Loyer E,Pawlik TM,Taouli B,Vauthey JN;Americas Hepato-Pancreato-Biliary Association;Society of Surgical Oncology;Society for Surgery of the Alimentary Tract.Selection for hepatic resection of colorectal liver metastases:expert consensus statement.HPB(Oxford)2013;15:91-103[PMID:23297719 DOI:10.1111/j.1477-2574.2012.00557.x]
14 Elleb?k SB,Fristrup CW,Mortensen MB.Intraoperative Ultrasound as a Screening Modality for the Detection of Liver Metastases during Resection of Primary Colorectal Cancer-ASystematic Review.Ultrasound Int Open 2017;3:E60-E68[PMID:28597000 DOI:10.1055/s-0043-100503]
15 Claudon M,Dietrich CF,Choi BI,Cosgrove DO,Kudo M,Nols?e CP,Piscaglia F,Wilson SR,Barr RG,Chammas MC,Chaubal NG,Chen MH,Clevert DA,Correas JM,Ding H,Forsberg F,Fowlkes JB,Gibson RN,Goldberg BB,Lassau N,Leen EL,Mattrey RF,Moriyasu F,Solbiati L,Weskott HP,Xu HX.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound(CEUS)in the liver--update 2012:a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB,AIUM,ASUM,FLAUS and ICUS.Ultraschall Med 2013;34:11-29[PMID:23129518 DOI:10.1055/s-0032-1325499]
16 Choi SH,Kim SY,Park SH,Kim KW,Lee JY,Lee SS,Lee MG.Diagnostic performance of CT,gadoxetate disodium-enhanced MRI,and PET/CT for the diagnosis of colorectal liver metastasis:Systematic review and meta-analysis.J Magn Reson Imaging2018;47:1237-1250[PMID:28901685 DOI:10.1002/jmri.25852]
17 Ko Y,Kim J,Park JK,Kim H,Cho JY,Kang SB,Ahn S,Lee KJ,Lee KH.Limited detection of small(≤10 mm)colorectal liver metastasis at preoperative CT in patients undergoing liver resection.PLo S One 2017;12:e0189797[PMID:29244853 DOI:10.1371/journal.pone.0189797]
18 Saing S,Haywood P,Duncan JK,Ma N,Cameron AL,Goodall S.Cost-effective imaging for resectability of liver lesions in colorectal cancer:an economic decision model.ANZ J Surg 2018;88:E507-E511[PMID:28982209 DOI:10.1111/ans.14194]
19 Dunet V,Halkic N,Prior JO,Anaye A,Meuli RA,Sempoux C,Denys A,Schmidt S.Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy:A Multiparametric PET/CT-MRI Study.Clin Nucl Med 2017;42:258-263[PMID:28166142 DOI:10.1097/RLU.0000000000001538]
20 Expert Panel on Gastrointestinal Imaging,Fowler KJ,Kaur H,Cash BD,Feig BW,Gage KL,Garcia EM,Hara AK,Herman JM,Kim DH,Lambert DL,Levy AD,Peterson CM,Scheirey CD,Small W Jr,Smith MP,Lalani T,Carucci LR.ACR Appropriateness Criteria?Pretreatment Staging of Colorectal Cancer.J Am Coll Radiol 2017;14:S234-S244[PMID:28473079 DOI:10.1016/j.jacr.2017.02.012]
21 Shim JR,Lee SD,Han SS,Lee SJ,Lee DE,Kim SK,Kim SH,Park SJ,Oh JH.Prognostic significance of 18F-FDG PET/CT in patients with colorectal cancer liver metastases after hepatectomy.Eur J Surg Oncol 2018;44:670-676[PMID:29459018 DOI:10.1016/j.ejso.2018.01.243]
22 Hall NC,Ruutiainen AT.Colorectal Cancer:Imaging Conundrums.Surg Oncol Clin N Am 2018;27:289-302[PMID:29496090 DOI:10.1016/j.soc.2017.11.004]
23 ViganòL,Lopci E,Costa G,Rodari M,Poretti D,Pedicini V,Solbiati L,Chiti A,Torzilli G.Positron Emission TomographyComputed Tomography for Patients with Recurrent Colorectal Liver Metastases:Impact on Restaging and Treatment Planning.Ann Surg Oncol 2017;24:1029-1036[PMID:27807727 DOI:10.1245/s10434-016-5644-y]
24 Abbadi RA,Sadat U,Jah A,Praseedom RK,Jamieson NV,Cheow HK,Whitley S,Ford HE,Wilson CB,Harper SJ,Huguet EL.Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.J Surg Oncol 2014;110:313-319[PMID:24737685DOI:10.1002/jso.23623]
25 Moulton CA,Gu CS,Law CH,Tandan VR,Hart R,Quan D,Fairfull Smith RJ,Jalink DW,Husien M,Serrano PE,Hendler AL,Haider MA,Ruo L,Gulenchyn KY,Finch T,Julian JA,Levine MN,Gallinger S.Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases:a randomized clinical trial.JAMA 2014;311:1863-1869[PMID:24825641 DOI:10.1001/jama.2014.3740]
26 Adam R,de Gramont A,Figueras J,Kokudo N,Kunstlinger F,Loyer E,Poston G,Rougier P,Rubbia-Brandt L,Sobrero A,Teh C,Tejpar S,Van Cutsem E,Vauthey JN,P?hlman L;of the EGOSLIM(Expert Group on OncoSurgery management of LIver Metastases)group.Managing synchronous liver metastases from colorectal cancer:a multidisciplinary international consensus.Cancer Treat Rev 2015;41:729-741[PMID:26417845 DOI:10.1016/j.ctrv.2015.06.006]
27 Arita J,Ono Y,Takahashi M,Inoue Y,Takahashi Y,Matsueda K,Saiura A.Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.Ann Surg 2015;262:1086-1091[PMID:26010441DOI:10.1097/SLA.0000000000001085]
28 Boogerd LS,Handgraaf HJ,Lam HD,Huurman VA,FarinaSarasqueta A,Frangioni JV,van de Velde CJ,Braat AE,Vahrmeijer AL.Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance.Surg Endosc 2017;31:952-961[PMID:27357928 DOI:10.1007/s00464-016-5007-6]
29 Lafaro K,Buettner S,Maqsood H,Wagner D,Bagante F,Spolverato G,Xu L,Kamel I,Pawlik TM.Defining Post Hepatectomy Liver Insufficiency:Where do We stand?J Gastrointest Surg 2015;19:2079-2092[PMID:26063080 DOI:10.1007/s11605-015-2872-6]
30 Martel G,Cieslak KP,Huang R,van Lienden KP,Wiggers JK,Belblidia A,Dagenais M,Lapointe R,van Gulik TM,Vandenbroucke-Menu F.Comparison of techniques for volumetric analysis of the future liver remnant:implications for major hepatic resections.HPB(Oxford)2015;17:1051-1057[PMID:26373675DOI:10.1111/hpb.12480]
31 Pulitano C,Crawford M,Joseph D,Aldrighetti L,Sandroussi C.Preoperative assessment of postoperative liver function:the importance of residual liver volume.J Surg Oncol 2014;110:445-450[PMID:24962104 DOI:10.1002/jso.23671]
32 Shindoh J,Tzeng CW,Aloia TA,Curley SA,Zimmitti G,Wei SH,Huang SY,Mahvash A,Gupta S,Wallace MJ,Vauthey JN.Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.Ann Surg Oncol 2013;20:2493-2500[PMID:23377564 DOI:10.1245/s10434-012-2864-7]
33 Takamoto T,Hashimoto T,Ichida A,Shimada K,Maruyama Y,Makuuchi M.Surgical Strategy Based on Indocyanine Green Test for Chemotherapy-Associated Liver Injury and LongTerm Outcome in Colorectal Liver Metastases.J Gastrointest Surg 2018;22:1077-1088[PMID:29488125 DOI:10.1007/s11605-018-3712-2]
34 Abdalla EK.Resection of colorectal liver metastases.J Gastro-intest Surg 2011;15:416-419[PMID:21301986 DOI:10.1007/s11605-011-1429-6]
35 Simpson AL,Geller DA,Hemming AW,Jarnagin WR,Clements LW,D’Angelica MI,Dumpuri P,G?nen M,Zendejas I,Miga MI,Stefansic JD.Liver planning software accurately predicts postoperative liver volume and measures early regeneration.J Am Coll Surg 2014;219:199-207[PMID:24862883 DOI:10.1016/j.jamcollsurg.2014.02.027]
36 Kanoria S,Robertson FP,Mehta NN,Fusai G,Sharma D,Davidson BR.Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis:A Pilot Randomised Controlled Feasibility Trial.World J Surg 2017;41:1322-1330[PMID:27933431 DOI:10.1007/s00268-016-3823-4]
37 Krieger PM,Tamandl D,Herberger B,Faybik P,Fleischmann E,Maresch J,Gruenberger T.Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.Ann Surg Oncol 2011;18:1644-1650[PMID:21207168 DOI:10.1245/s10434-010-1494-1]
38 Wakiya T,Kudo D,Toyoki Y,Ishido K,Kimura N,Narumi S,Kijima H,Hakamada K.Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis.Ann Surg Oncol 2014;21:167-172[PMID:23959055 DOI:10.1245/s10434-013-3203-3]
39 Erdogan D,Heijnen BH,Bennink RJ,Kok M,Dinant S,Straatsburg IH,Gouma DJ,van Gulik TM.Preoperative assessment of liver function:a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.Liver Int 2004;24:117-123[PMID:15078475 DOI:10.1111/j.1478-3231.2004.00901.x]
40 Cieslak KP,Bennink RJ,de Graaf W,van Lienden KP,Besselink MG,Busch OR,Gouma DJ,van Gulik TM.Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.HPB(Oxford)2016;18:773-780[PMID:27593595 DOI:10.1016/j.hpb.2016.06.006]
41 Ihnát P,Vávra P,Zon?a P.Treatment strategies for colorectal carcinoma with synchronous liver metastases:Which way to go?World J Gastroenterol 2015;21:7014-7021[PMID:26078580DOI:10.3748/wjg.v21.i22.7014]
42 Vallance AE,van der Meulen J,Kuryba A,Charman SC,Botterill ID,Prasad KR,Hill J,Jayne DG,Walker K.The timing of liver resection in patients with colorectal cancer and synchronous liver metastases:a population-based study of current practice and survival.Colorectal Dis 2018;20:486-495[PMID:29338108DOI:10.1111/codi.14019]
43 Sturesson C,Valdimarsson VT,Blomstrand E,Eriksson S,Nilsson JH,Syk I,Lindell G.Liver-first strategy for synchronous colorectal liver metastases-an intention-to-treat analysis.HPB(Oxford)2017;19:52-58[PMID:27838252 DOI:10.1016/j.hpb.2016.10.005]
44 Esposito F,Lim C,Sa Cunha A,Pessaux P,Navarro F,Azoulay D;French Colorectal Liver Metastases Working Group,Association Fran?aise de Chirurgie(AFC).Primary Tumor Versus LiverFirst Approach for Synchronous Colorectal Liver Metastases:An Association Fran?aise de Chirurgie(AFC)Multicenter-Based Study with Propensity Score Analysis.World J Surg 2018[PMID:29947991 DOI:10.1007/s00268-018-4711-x]
45 Valdimarsson VT,Syk I,Lindell G,Norén A,Isaksson B,Sandstr?m P,Rizell M,Ardnor B,Sturesson C.Outcomes of liverfirst strategy and classical strategy for synchronous colorectal liver metastases in Sweden.HPB(Oxford)2018;20:441-447[PMID:29242035 DOI:10.1016/j.hpb.2017.11.004]
46 Le Souder EB,Azin A,Hirpara DH,Walker R,Cleary S,Quereshy F.Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model.J Surg Oncol 2018;117:1376-1385[PMID:29484664 DOI:10.1002/jso.25020]
47 Welsh FK,Chandrakumaran K,John TG,Cresswell AB,Rees M.Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases.Br J Surg2016;103:600-606[PMID:26864820 DOI:10.1002/bjs.10099]
48 Mizuno T,Cloyd JM,Omichi K,Chun YS,Conrad C,Tzeng CD,Wei SH,Aloia TA,Vauthey JN.Two-Stage Hepatectomy vs OneStage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases.J Am Coll Surg2018;226:825-834[PMID:29454099 DOI:10.1016/j.jamcollsurg.2018.01.054]
49 Slesser AA,Simillis C,Goldin R,Brown G,Mudan S,Tekkis PP.A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases.Surg Oncol 2013;22:36-47[PMID:23253399 DOI:10.1016/j.suronc.2012.11.002]
50 Silberhumer GR,Paty PB,Denton B,Guillem J,Gonen M,Araujo RLC,Nash GM,Temple LK,Allen PJ,DeMatteo RP,Weiser MR,Wong WD,Jarnagin WR,D’Angelica MI,Fong Y.Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer.Surgery 2016;160:67-73[PMID:27079362 DOI:10.1016/j.surg.2016.02.029]
51 Abelson JS,Michelassi F,Sun T,Mao J,Milsom J,Samstein B,Sedrakyan A,Yeo HL.Simultaneous Resection for Synchronous Colorectal Liver Metastasis:the New Standard of Care?JGastrointest Surg 2017;21:975-982[PMID:28411351 DOI:10.1007/s11605-017-3422-1]
52 Gavriilidis P,Sutcliffe RP,Hodson J,Marudanayagam R,Isaac J,Azoulay D,Roberts KJ.Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases:a systematic review and meta-analysis.HPB(Oxford)2018;20:11-19[PMID:28888775 DOI:10.1016/j.hpb.2017.08.008]
53 Nanji S,Mackillop WJ,Wei X,Booth CM.Simultaneous resection of primary colorectal cancer and synchronous liver metastases:a population-based study.Can J Surg 2017;60:122-128[PMID:28234215 DOI:10.1503/cjs.008516]
54 Yin Z,Liu C,Chen Y,Bai Y,Shang C,Yin R,Yin D,Wang J.Timing of hepatectomy in resectable synchronous colorectal liver metastases(SCRLM):Simultaneous or delayed?Hepatology 2013;57:2346-2357[PMID:23359206 DOI:10.1002/hep.26283]
55 Berardi G,De Man M,Laurent S,Smeets P,Tomassini F,Ariotti R,Hoorens A,van Dorpe J,Varin O,Geboes K,Troisi RI.Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.Eur J Surg Oncol 2018;44:1069-1077[PMID:29615295 DOI:10.1016/j.ejso.2018.03.008]
56 Kim CW,Lee JL,Yoon YS,Park IJ,Lim SB,Yu CS,Kim TW,Kim JC.Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases:Apropensity score matching analysis.Medicine(Baltimore)2017;96:e6174[PMID:28207557 DOI:10.1097/MD.0000000000006174]
57 Creasy JM,Sadot E,Koerkamp BG,Chou JF,Gonen M,Kemeny NE,Balachandran VP,Kingham TP,DeMatteo RP,Allen PJ,Blumgart LH,Jarnagin WR,D’Angelica MI.Actual 10-year survival after hepatic resection of colorectal liver metastases:what factors preclude cure?Surgery 2018;163:1238-1244[PMID:29455841 DOI:10.1016/j.surg.2018.01.004]
58 Acciuffi S,Meyer F,Bauschke A,Settmacher U,Lippert H,Croner R,Altendorf-Hofmann A.Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer:a 22-year bicentre study.J Cancer Res Clin Oncol 2018;144:593-599[PMID:29340767 DOI:10.1007/s00432-018-2583-y]
59 Lim C,Doussot A,Osseis M,Esposito F,Salloum C,Calderaro J,Tournigand C,Azoulay D.Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.Clin Transl Oncol 2018;20:1274-1279[PMID:29594943 DOI:10.1007/s12094-018-1858-8]
60 Primrose J,Falk S,Finch-Jones M,Valle J,O’Reilly D,Siriwardena A,Hornbuckle J,Peterson M,Rees M,Iveson T,Hickish T,Butler R,Stanton L,Dixon E,Little L,Bowers M,Pugh S,Garden OJ,Cunningham D,Maughan T,Bridgewater J.Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis:the New EPOC randomised controlled trial.Lancet Oncol 2014;15:601-611[PMID:24717919DOI:10.1016/S1470-2045(14)70105-6]
61 Kishiki T,Lapin B,Matsuoka H,Watanabe T,Takayasu K,Kojima K,Sugihara K,Masaki T.Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer:A Multicenter Retrospective Study.Dis Colon Rectum 2018;61:51-57[PMID:29215480 DOI:10.1097/DCR.0000000000000950]
62 Memeo R,de Blasi V,Adam R,GoéréD,Piardi T,Lermite E,Turrini O,Navarro F,de’Angelis N,Cunha AS,Pessaux P;French Colorectal Liver Metastases Working Group,Association Fran?aise de Chirurgie(AFC).Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases:APropensity Score Matching Analysis.World J Surg 2018;42:892-901[PMID:28929341 DOI:10.1007/s00268-017-4229-7]
63 Sadot E,Groot Koerkamp B,Leal JN,Shia J,Gonen M,Allen PJ,DeMatteo RP,Kingham TP,Kemeny N,Blumgart LH,Jarnagin WR,D’Angelica MI.Resection margin and survival in 2368patients undergoing hepatic resection for metastatic colorectal cancer:surgical technique or biologic surrogate?Ann Surg 2015;262:476-485;discussion 483-485[PMID:26258316 DOI:10.1097/SLA.0000000000001427]
64 Sasaki K,Margonis GA,Maitani K,Andreatos N,Wang J,Pikoulis E,He J,Wolfgang CL,Weiss M,Pawlik TM.The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion.Ann Surg Oncol 2017;24:2438-2446[PMID:28695393 DOI:10.1245/s10434-017-5904-5]
65 Margonis GA,Sergentanis TN,Ntanasis-Stathopoulos I,Andreatos N,Tzanninis IG,Sasaki K,Psaltopoulou T,Wang J,Buettner S,PapaloisΑE,He J,Wolfgang CL,Pawlik TM,Weiss MJ.Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases:A Systematic Review and Meta-analysis.Ann Surg 2018;267:1047-1055[PMID:29189379 DOI:10.1097/SLA.0000000000002552]
66 Dhir M,Lyden ER,Wang A,Smith LM,Ullrich F,Are C.Influence of margins on overall survival after hepatic resection for colorectal metastasis:a meta-analysis.Ann Surg 2011;254:234-242[PMID:21694583 DOI:10.1097/SLA.0b013e318223c609]
67 Margonis GA,Sasaki K,Andreatos N,Kim Y,Merath K,Wagner D,Wilson A,Buettner S,Amini N,Antoniou E,Pawlik TM.KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.Ann Surg Oncol 2017;24:264-271[PMID:27696170 DOI:10.1245/s10434-016-5609-1]
68 Hamady ZZ,Lodge JP,Welsh FK,Toogood GJ,White A,John T,Rees M.One-millimeter cancer-free margin is curative for colorectal liver metastases:a propensity score case-match approach.Ann Surg 2014;259:543-548[PMID:23732261 DOI:10.1097/SLA.0b013e3182902b6e]
69 Truant S,Séquier C,Leteurtre E,Boleslawski E,Elamrani M,Huet G,Duhamel A,Hebbar M,Pruvot FR.Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens.HPB(Oxford)2015;17:176-184[PMID:25041611DOI:10.1111/hpb.12316]
70 Moris D,Ronnekleiv-Kelly S,Rahnemai-Azar AA,Felekouras E,Dillhoff M,Schmidt C,Pawlik TM.Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases:a Systematic Review.J Gastrointest Surg 2017;21:1076-1085[PMID:28364212 DOI:10.1007/s11605-017-3397-y]
71 Margonis GA,Sasaki K,Kim Y,Samaha M,Buettner S,Amini N,Antoniou E,Pawlik TM.Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.J Gastrointest Surg 2016;20:1821-1829[PMID:27384430 DOI:10.1007/s11605-016-3198-8]
72 Brunner SM,Kesselring R,Rubner C,Martin M,Jeiter T,Boerner T,Ruemmele P,Schlitt HJ,Fichtner-Feigl S.Prognosis according to histochemical analysis of liver metastases removed at liver resection.Br J Surg 2014;101:1681-1691[PMID:25331841 DOI:10.1002/bjs.9627]
73 Laurent C,Adam JP,Denost Q,Smith D,Saric J,Chiche L.Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.World J Surg 2016;40:1191-1199[PMID:26757718 DOI:10.1007/s00268-016-3404-6]
74 Sasaki K,Margonis GA,Andreatos N,Wilson A,Weiss M,Wolfgang C,Sergentanis TN,Polychronidis G,He J,Pawlik TM.Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.Br J Surg 2017;104:926-935[PMID:28266705 DOI:10.1002/bjs.10510]
75 Makowiec F,Bronsert P,Klock A,Hopt UT,Neeff HP.Prognostic influence of hepatic margin after resection of colorectal liver metastasis:role of modern preoperative chemotherapy.Int JColorectal Dis 2018;33:71-78[PMID:29098384 DOI:10.1007/s00384-017-2916-3]
76 Wang Y,Wang ZQ,Wang FH,Yuan YF,Li BK,Ding PR,Chen G,Wu XJ,Lu ZH,Pan ZZ,Wan DS,Sun P,Yan SM,Xu RH,Li YH.The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy:Is the Treatment Worthwhile?J Cancer 2017;8:1179-1186[PMID:28607592 DOI:10.7150/jca.18091]
77 Strandberg Holka P,Eriksson S,Eberhard J,Bergenfeldt M,Lindell G,Sturesson C.Significance of poor performance status after resection of colorectal liver metastases.World J Surg Oncol2018;16:3[PMID:29304822 DOI:10.1186/s12957-017-1306-1]
78 Gillams A,Goldberg N,Ahmed M,Bale R,Breen D,Callstrom M,Chen MH,Choi BI,de Baere T,Dupuy D,Gangi A,Gervais D,Helmberger T,Jung EM,Lee F,Lencioni R,Liang P,Livraghi T,Lu D,Meloni F,Pereira P,Piscaglia F,Rhim H,Salem R,Sofocleous C,Solomon SB,Soulen M,Tanaka M,Vogl T,Wood B,Solbiati L.Thermal ablation of colorectal liver metastases:a position paper by an international panel of ablation experts,The Interventional Oncology Sans Frontières meeting 2013.Eur Radiol2015;25:3438-3454[PMID:25994193 DOI:10.1007/s00330-015-3779-z]
79 Ruers T,Punt C,Van Coevorden F,Pierie JP,Borel-Rinkes I,Ledermann JA,Poston G,Bechstein W,Lentz MA,Mauer M,Van Cutsem E,Lutz MP,Nordlinger B;EORTC Gastro-Intestinal Tract Cancer Group,Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie(ALM-CAO)and the National Cancer Research Institute Colorectal Clinical Study Group(NCRI CCSG).Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases:a randomized EORTC Intergroup phaseⅡstudy(EORTC 40004).Ann Oncol2012;23:2619-2626[PMID:22431703 DOI:10.1093/annonc/mds053]
80 He N,Jin QN,Wang D,Yang YM,Liu YL,Wang GB,Tao KX.Radiofrequency ablation vs.hepatic resection for resectable colorectal liver metastases.J Huazhong Univ Sci Technolog Med Sci 2016;36:514-518[PMID:27465325 DOI:10.1007/s11596-016-1617-4]
81 van Amerongen MJ,Jenniskens SFM,van den Boezem PB,Fütterer JJ,de Wilt JHW.Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases-a meta-analysis.HPB(Oxford)2017;19:749-756[PMID:28687147 DOI:10.1016/j.hpb.2017.05.011]
82 Correa-Gallego C,Fong Y,Gonen M,D’Angelica MI,Allen PJ,DeMatteo RP,Jarnagin WR,Kingham TP.A retrospective comparison of microwave ablation vs.radiofrequency ablation for colorectal cancer hepatic metastases.Ann Surg Oncol 2014;21:4278-4283[PMID:24889486 DOI:10.1245/s10434-014-3817-0]
83 Yang B,Li Y.A comparative study of laparoscopic microwave ablation with laparoscopic radiofrequency ablation for colorectal liver metastasis.J BUON 2017;22:667-672[PMID:28730772]
84 Mulier S,Ruers T,Jamart J,Michel L,Marchal G,Ni Y.Radiofrequency ablation versus resection for resectable colorectal liver metastases:time for a randomized trial?An update.Dig Surg2008;25:445-460[PMID:19212117 DOI:10.1159/000184736]
85 Imai K,Allard MA,Castro Benitez C,Vibert E,Sa Cunha A,Cherqui D,Castaing D,Baba H,Adam R.Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.Br J Surg2017;104:570-579[PMID:28112813 DOI:10.1002/bjs.10447]
86 Evrard S,Poston G,Kissmeyer-Nielsen P,Diallo A,Desolneux G,Brouste V,Lalet C,Mortensen F,St?ttner S,Fenwick S,Malik H,Konstantinidis I,DeMatteo R,D’Angelica M,Allen P,Jarnagin W,Mathoulin-Pelissier S,Fong Y.Combined ablation and resection(CARe)as an effective parenchymal sparing treatment for extensive colorectal liver metastases.PLo S One 2014;9:e114404[PMID:25485541 DOI:10.1371/journal.pone.0114404]
87 Mise Y,Aloia TA,Brudvik KW,Schwarz L,Vauthey JN,Conrad C.Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival.Ann Surg 2016;263:146-152[PMID:25775068 DOI:10.1097/SLA.0000000000001194]
88 DupréA,Jones RP,Diaz-Nieto R,Fenwick SW,Poston GJ,Malik HZ.Curative-intent treatment of recurrent colorectal liver metastases:A comparison between ablation and resection.Eur JSurg Oncol 2017;43:1901-1907[PMID:28888801 DOI:10.1016/j.ejso.2017.08.008]
89 Aliyev S,Agcaoglu O,Aksoy E,Taskin HE,Vogt D,Fung J,Siperstein A,Berber E.Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis.Surgery 2013;154:556-562[PMID:23859307DOI:10.1016/j.surg.2013.03.009]
90 Ringe KI,Lutat C,Rieder C,Schenk A,Wacker F,Raatschen HJ.Experimental Evaluation of the Heat Sink Effect in Hepatic Microwave Ablation.PLoS One 2015;10:e0134301[PMID:26222431 DOI:10.1371/journal.pone.0134301]
91 Fretland?A,Dagenborg VJ,Bj?rnelv GMW,Kazaryan AM,Kristiansen R,Fagerland MW,Hausken J,T?nnessen TI,Abildgaard A,Barkhatov L,Yaqub S,R?sok BI,Bj?rnbeth BA,Andersen MH,Flatmark K,Aas E,Edwin B.Laparoscopic Versus Open Resection for Colorectal Liver Metastases:The OSLO-COMET Randomized Controlled Trial.Ann Surg 2018;267:199-207[PMID:28657937DOI:10.1097/SLA.0000000000002353]
92 Xie SM,Xiong JJ,Liu XT,Chen HY,Iglesia-García D,Altaf K,Bharucha S,Huang W,Nunes QM,Szatmary P,Liu XB.Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases:A Comprehensive Systematic Review and Metaanalysis.Sci Rep 2017;7:1012[PMID:28432295 DOI:10.1038/s41598-017-00978-z]
93 Montalti R,Berardi G,Laurent S,Sebastiani S,Ferdinande L,Libbrecht LJ,Smeets P,Brescia A,Rogiers X,de Hemptinne B,Geboes K,Troisi RI.Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability:Oncological outcomes of a case-control matched-pairs analysis.Eur J Surg Oncol 2014;40:536-544[PMID:24555996 DOI:10.1016/j.ejso.2014.01.005]
94 Di Fabio F,Barkhatov L,Bonadio I,Dimovska E,Fretland?A,Pearce NW,Troisi RI,Edwin B,Abu Hilal M.The impact of laparoscopic versus open colorectal cancer surgery on subsequent laparoscopic resection of liver metastases:A multicenter study.Surgery 2015;157:1046-1054[PMID:25835216 DOI:10.1016/j.surg.2015.01.007]
95 Efanov M,Alikhanov R,Tsvirkun V,Kazakov I,Melekhina O,Kim P,Vankovich A,Grendal K,Berelavichus S,Khatkov I.Comparative analysis of learning curve in complex robot-assisted and laparoscopic liver resection.HPB(Oxford)2017;19:818-824[PMID:28599892 DOI:10.1016/j.hpb.2017.05.003]
96 Nota CLMA,Molenaar IQ,van Hillegersberg R,Borel Rinkes IHM,Hagendoorn J.Robotic liver resection including the posterosuperior segments:initial experience.J Surg Res 2016;206:133-138[PMID:27916352 DOI:10.1016/j.jss.2016.06.079]
97 Wang WH,Kuo KK,Wang SN,Lee KT.Oncological and surgical result of hepatoma after robot surgery.Surg Endosc 2018;32:3918-3924[PMID:29488090 DOI:10.1007/s00464-018-6131-2]
98 Takahashi S,Konishi M,Kinoshita T,Gotohda N,Kato Y,Saito N,Sugito M,Yoshino T.Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis.J Gastrointest Surg 2013;17:939-948[PMID:23400510 DOI:10.1007/s11605-013-2162-0]
99 Charnsangavej C,Clary B,Fong Y,Grothey A,Pawlik TM,Choti MA.Selection of patients for resection of hepatic colorectal metastases:expert consensus statement.Ann Surg Oncol 2006;13:1261-1268[PMID:16947009 DOI:10.1245/s10434-006-9023-y]
100 Xiao N,Yu K,Yu S,Wu J,Wang J,Shan S,Zheng S,Wang L,Wang J,Peng S.The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis:a case report and literature review.World J Surg Oncol 2017;15:148[PMID:28774330 DOI:10.1186/s12957-017-1212-6]
101 Simoneau E,Alanazi R,Alshenaifi J,Molla N,Aljiffry M,Medkhali A,Boucher LM,Asselah J,Metrakos P,Hassanain M.Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases.J Surg Oncol 2016;113:449-455[PMID:26955907 DOI:10.1002/jso.24139]
102 Cassinotto C,Dohan A,Gallix B,Simoneau E,Boucher LM,Metrakos P,Cabrera T,Torres C,Muchantef K,Valenti DA.Portal Vein Embolization in the Setting of Staged Hepatectomy with Preservation of Segment IV±I Only for Bilobar Colorectal Liver Metastases:Safety,Efficacy,and Clinical Outcomes.J Vasc Interv Radiol 2017;28:963-970[PMID:28283401 DOI:10.1016/j.jvir.2017.01.001]
103 Huiskens J,Olthof PB,van der Stok EP,Bais T,van Lienden KP,Moelker A,Krumeich J,Roumen RM,Grünhagen DJ,Punt CJA,van Amerongen M,de Wilt JHW,Verhoef C,Van Gulik TM.Does portal vein embolization prior to liver resection influence the oncological outcomes-A propensity score matched comparison.Eur J Surg Oncol 2018;44:108-114[PMID:29126672 DOI:10.1016/j.ejso.2017.09.017]
104 Ironside N,Bell R,Bartlett A,McCall J,Powell J,Pandanaboyana S.Systematic review of perioperative and survival outcomes of liver resections with and without preoperative portal vein embolization for colorectal metastases.HPB(Oxford)2017;19:559-566[PMID:28438427 DOI:10.1016/j.hpb.2017.03.003]
105 Elias D,De Baere T,Roche A,Mducreux,Leclere J,Lasser P.During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma.Br J Surg 1999;86:784-788[PMID:10383579 DOI:10.1046/j.1365-2168.1999.01154.x]
106 Kokudo N,Tada K,Seki M,Ohta H,Azekura K,Ueno M,Ohta K,Yamaguchi T,Matsubara T,Takahashi T,Nakajima T,Muto T,Ikari T,Yanagisawa A,Kato Y.Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization.Hepatology 2001;34:267-272[PMID:11481611DOI:10.1053/jhep.2001.26513]
107 Yamashita S,Sakamoto Y,Yamamoto S,Takemura N,Omichi K,Shinkawa H,Mori K,Kaneko J,Akamatsu N,Arita J,Hasegawa K,Kokudo N.Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma,Biliary Tract Cancer,and Colorectal Liver Metastases:A Comparative Study Based on Single-Center Experience of 319 Cases.Ann Surg Oncol2017;24:1557-1568[PMID:28188502 DOI:10.1245/s10434-017-5800-z]
108 Isfordink CJ,Samim M,Braat MNGJA,Almalki AM,Hagendoorn J,Borel Rinkes IHM,Molenaar IQ.Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant:A systematic review and metaanalysis.Surg Oncol 2017;26:257-267[PMID:28807245 DOI:10.1016/j.suronc.2017.05.001]
109 Levi Sandri GB,Santoro R,Vennarecci G,Lepiane P,Colasanti M,Ettorre GM.Two-stage hepatectomy,a 10 years experience.Updates Surg 2015;67:401-405[PMID:26534726 DOI:10.1007/s13304-015-0332-1]
110 Lam VW,Laurence JM,Johnston E,Hollands MJ,Pleass HC,Richardson AJ.A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases.HPB(Oxford)2013;15:483-491[PMID:23750490 DOI:10.1111/j.1477-2574.2012.00607.x]
111 Schnitzbauer AA,Lang SA,Goessmann H,Nadalin S,Baumgart J,Farkas SA,Fichtner-Feigl S,Lorf T,Goralcyk A,H?rbelt R,Kroemer A,Loss M,Rümmele P,Scherer MN,Padberg W,K?nigsrainer A,Lang H,Obed A,Schlitt HJ.Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.Ann Surg 2012;255:405-414[PMID:22330038 DOI:10.1097/SLA.0b013e31824856f5]
112 Sandstr?m P,R?sok BI,Sparrelid E,Larsen PN,Larsson AL,Lindell G,Schultz NA,Bj?rnbeth BA,Isaksson B,Rizell M,Bj?rnsson B.ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis:Results From a Scandinavian Multicenter Randomized Controlled Trial(LIGRO Trial).Ann Surg 2018;267:833-840[PMID:28902669 DOI:10.1097/SLA.0000000000002511]
113 Ratti F,Schadde E,Masetti M,Massani M,Zanello M,Serenari M,Cipriani F,Bonariol L,Bassi N,Aldrighetti L,Jovine E.Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases:A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy.Ann Surg Oncol 2015;22:1933-1942[PMID:25564160 DOI:10.1245/s10434-014-4291-4]
114 Olthof PB,Huiskens J,Wicherts DA,Huespe PE,Ardiles V,Robles-Campos R,Adam R,Linecker M,Clavien PA,Koopman M,Verhoef C,Punt CJ,van Gulik TM,de Santibanes E.Survival after associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)for advanced colorectal liver metastases:A case-matched comparison with palliative systemic therapy.Surgery 2017;161:909-919[PMID:28038862 DOI:10.1016/j.surg.2016.10.032]
115 Moris D,Ronnekleiv-Kelly S,Kostakis ID,Tsilimigras DI,Beal EW,Papalampros A,Dimitroulis D,Felekouras E,Pawlik TM.Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy(ALPPS)Versus Two-Stage Hepatectomy(TSH)in Patients with Unresectable Colorectal Liver Metastases:A Systematic Review and Meta-Analysis.World J Surg 2018;42:806-815[PMID:28798996 DOI:10.1007/s00268-017-4181-6]
116 Maulat C,Philis A,Charriere B,Mokrane FZ,Guimbaud R,Otal P,Suc B,Muscari F.Rescue associating liver partition and portal vein ligation for staged hepatectomy after portal embolization:Our experience and literature review.World J Clin Oncol 2017;8:351-359[PMID:28848702 DOI:10.5306/wjco.v8.i4.351]
117 Sparrelid E,Gilg S,Brismar TB,Lundell L,Isaksson B.Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases.Langenbecks Arch Surg2017;402:69-75[PMID:27761713 DOI:10.1007/s00423-016-1524-y]
118 Serenari M,Alvarez FA,Ardiles V,de Santiba?es M,Pekolj J,de Santiba?es E.The ALPPS Approach for Colorectal Liver Metastases:Impact of KRAS Mutation Status in Survival.Dig Surg2018;35:303-310[PMID:29032374 DOI:10.1159/000471930]
119 Zattar-Ramos LC,Bezerra RO,Siqueira LT,Marques DT,Menezes MR,Herman P,Machado MA,Cerri GG,Leite CC.Associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)in colorectal liver metastasis:the radiologist’s perspective.Abdom Radiol(NY)2016;41:2150-2160[PMID:27377899 DOI:10.1007/s00261-016-0832-6]
120 Maeda Y,Shinohara T,Nagatsu A,Futakawa N,Hamada T.Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.Ann Surg Oncol2016;23 Suppl 2:S242-S248[PMID:25749931 DOI:10.1245/s10434-015-4460-0]
121 Nozawa H,Ishihara S,Kawai K,Hata K,Kiyomatsu T,Tanaka T,Nishikawa T,Otani K,Yasuda K,Sasaki K,Kaneko M,Murono K.Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal CancerPredictive Factors and Prognosis.Clin Colorectal Cancer 2018;17:e91-e97[PMID:29113730 DOI:10.1016/j.clcc.2017.10.002]
122 Pak LM,Kemeny NE,Capanu M,Chou JF,Boucher T,Cercek A,Balachandran VP,Kingham TP,Allen PJ,DeMatteo RP,Jarnagin WR,D’Angelica MI.Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases:Long term results and curative potential.J Surg Oncol 2018;117:634-643[PMID:29165816DOI:10.1002/jso.24898]
123 Rouyer M,Fran?ois E,Cunha AS,Monnereau A,Noize P,Robinson P,Droz-Perroteau C,Le Monies de Sagazan A,JovéJ,Lassalle R,Moore N,Fourrier-Réglat A,Smith D;EREBUSStudy Group.Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice:Results of the EREBUSCohort.Clin Colorectal Cancer 2018;17:129-139[PMID:29523416 DOI:10.1016/j.clcc.2018.01.007]
124 Tomasello G,Petrelli F,Ghidini M,Russo A,Passalacqua R,Barni S.FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer:A Systematic Review and Pooled Analysis.JAMA Oncol 2017;3:e170278[PMID:28542671 DOI:10.1001/jamaoncol.2017.0278]
125 Carrato A,Abad A,Massuti B,Grávalos C,Escudero P,LongoMu?oz F,Manzano JL,Gómez A,Safont MJ,Gallego J,GarcíaParedes B,Pericay C,Due?as R,Rivera F,Losa F,ValladaresAyerbes M,González E,Aranda E;Spanish Cooperative Group for the Treatment of Digestive Tumours(TTD).First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases:A randomised,phase II trial(PLANET-TTD).Eur J Cancer 2017;81:191-202[PMID:28633089 DOI:10.1016/j.ejca.2017.04.024]
126 Andreatos N,Ronnekleiv-Kelly S,Margonis GA,Sasaki K,Gani F,Amini N,Wilson A,Pawlik TM.From bench to bedside:Clinical implications of KRAS status in patients with colorectal liver metastasis.Surg Oncol 2016;25:332-338[PMID:27566041 DOI:10.1016/j.suronc.2016.07.002]
127 Venook AP,Niedzwiecki D,Lenz HJ,Innocenti F,Fruth B,Meyerhardt JA,Schrag D,Greene C,O’Neil BH,Atkins JN,Berry S,Polite BN,O’Reilly EM,Goldberg RM,Hochster HS,Schilsky RL,Bertagnolli MM,El-Khoueiry AB,Watson P,Benson AB 3rd,Mulkerin DL,Mayer RJ,Blanke C.Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer:A Randomized Clinical Trial.JAMA 2017;317:2392-2401[PMID:28632865 DOI:10.1001/jama.2017.7105]
128 Gruenberger T,Bridgewater J,Chau I,García Alfonso P,Rivoire M,Mudan S,Lasserre S,Hermann F,Waterkamp D,Adam R.Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer:the OLIVIA multinational randomised phase II trial.Ann Oncol 2015;26:702-708[PMID:25538173 DOI:10.1093/annonc/mdu580]
129 Hatano E,Okuno M,Nakamura K,Ishii T,Seo S,Taura K,Yasuchika K,Yazawa T,Zaima M,Kanazawa A,Terajima H,Kaihara S,Adachi Y,Inoue N,Furumoto K,Manaka D,Tokka A,Furuyama H,Doi K,Hirose T,Horimatsu T,Hasegawa S,Matsumoto S,Sakai Y,Uemoto S.Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis(BECKstudy).J Hepatobiliary Pancreat Sci 2015;22:634-645[PMID:25926024 DOI:10.1002/jhbp.254]
130 Boeckx N,Koukakis R,Op de Beeck K,Rolfo C,Van Camp G,Siena S,Tabernero J,Douillard JY,AndréT,Peeters M.Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer:results from two randomized firstline panitumumab studies.Ann Oncol 2017;28:1862-1868[PMID:28449055 DOI:10.1093/annonc/mdx119]
131 Peeters M,Price T,Taieb J,Geissler M,Rivera F,Canon JL,Pentheroudakis G,Koukakis R,Burdon P,Siena S.Relationships between tumour response and primary tumour location,and predictors of long-term survival,in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy:retrospective analyses of the PRIME and PEAK clinical trials.Br J Cancer 2018;119:303-312[PMID:30013091 DOI:10.1038/s41416-018-0165-z]
132 Brandi G,De Lorenzo S,Nannini M,Curti S,Ottone M,Dall’Olio FG,Barbera MA,Pantaleo MA,Biasco G.Adjuvant chemotherapy for resected colorectal cancer metastases:Literature review and meta-analysis.World J Gastroenterol 2016;22:519-533[PMID:26811604 DOI:10.3748/wjg.v22.i2.519]
133 Taieb J,Rivera F,Siena S,Karthaus M,Valladares-Ayerbes M,Gallego J,Geissler M,Koukakis R,Demonty G,Peeters M.Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.J Cancer Res Clin Oncol 2018;144:321-335[PMID:29080924 DOI:10.1007/s00432-017-2534-z]
134 Rivera F,Karthaus M,Hecht JR,Sevilla I,Forget F,Fasola G,Canon JL,Guan X,Demonty G,Schwartzberg LS.Final analysis of the randomised PEAK trial:overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.Int J Colorectal Dis 2017;32:1179-1190[PMID:28424871 DOI:10.1007/s00384-017-2800-1]
135 Nagai Y,Beppu T,Sakamoto Y,Miyamoto Y,Hayashi H,Nitta H,Imai K,Masuda T,Okabe H,Hirashima K,Imamura Y,Baba Y,Chikamoto A,Baba H.Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.Anticancer Res 2014;34:5529-5535[PMID:25275051]
136 Ravaioli M,Ercolani G,Neri F,Cescon M,Stacchini G,Del Gaudio M,Cucchetti A,Pinna AD.Liver transplantation for hepatic tumors:a systematic review.World J Gastroenterol 2014;20:5345-5352[PMID:24833864 DOI:10.3748/wjg.v20.i18.5345]
137 Gorgen A,Muaddi H,Zhang W,McGilvray I,Gallinger S,Sapisochin G.The New Era of Transplant Oncology:Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases.Can J Gastroenterol Hepatol 2018;2018:9531925[PMID:29623268 DOI:10.1155/2018/9531925]
138 Toso C,Pinto Marques H,Andres A,Castro Sousa F,Adam R,Kalil A,Clavien PA,Furtado E,Barroso E,Bismuth H;Compagnons Hépato-Biliaires Group.Liver transplantation for colorectal liver metastasis:Survival without recurrence can be achieved.Liver Transpl 2017;23:1073-1076[PMID:28544246DOI:10.1002/lt.24791]
139 Dueland S,Guren TK,Hagness M,Glimelius B,Line PD,Pfeiffer P,Foss A,Tveit KM.Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?Ann Surg 2015;261:956-960[PMID:24950280 DOI:10.1097/SLA.0000000000000786]
140 Hagness M,Foss A,Line PD,Scholz T,J?rgensen PF,Fosby B,Boberg KM,Mathisen O,Gladhaug IP,Egge TS,Solberg S,Hausken J,Dueland S.Liver transplantation for nonresectable liver metastases from colorectal cancer.Ann Surg 2013;257:800-806[PMID:23360920 DOI:10.1097/SLA.0b013e3182823957]
141 Moris D,Tsilimigras DI,Chakedis J,Beal EW,Felekouras E,Vernadakis S,Schizas D,Fung JJ,Pawlik TM.Liver transplantation for unresectable colorectal liver metastases:A systematic review.JSurg Oncol 2017;116:288-297[PMID:28513862 DOI:10.1002/jso.24671]
142 de Jong MC,Pulitano C,Ribero D,Strub J,Mentha G,Schulick RD,Choti MA,Aldrighetti L,Capussotti L,Pawlik TM.Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis:an international multi-institutional analysis of 1669 patients.Ann Surg 2009;250:440-448[PMID:19730175 DOI:10.1097/SLA.0b013e3181b4539b]
143 Fukami Y,Kaneoka Y,Maeda A,Takayama Y,Onoe S.Postoperative complications following aggressive repeat hepatectomy for colorectal liver metastasis have adverse oncological outcomes.Surg Today 2017;47:99-107[PMID:27117689 DOI:10.1007/s00595-016-1340-6]
144 Neal CP,Nana GR,Jones M,Cairns V,Ngu W,Isherwood J,Dennison AR,Garcea G.Repeat hepatectomy is independently associated with favorable long-term outcome in patients with colorectal liver metastases.Cancer Med 2017;6:331-338[PMID:28101946 DOI:10.1002/cam4.872]
145 Wurster EF,Tenckhoff S,Probst P,Jensen K,D?lger E,Knebel P,Diener MK,Büchler MW,Ulrich A.A systematic review and metaanalysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases.HPB(Oxford)2017;19:491-497[PMID:28347640 DOI:10.1016/j.hpb.2017.02.440]
146 Heise D,Bayings W,Tuinhof A,Eickhoff R,Kroh A,Ulmer F,Dejong CHC,Neumann U,Binneb?sel M.Long-term outcome and quality of life after initial and repeat resection of colorectal liver metastasis:A retrospective analysis.Int J Surg 2017;48:281-285[PMID:29175019 DOI:10.1016/j.ijsu.2017.11.032]
147 Oba M,Hasegawa K,Shindoh J,Yamashita S,Sakamoto Y,Makuuchi M,Kokudo N.Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases.Surgery 2016;159:632-640[PMID:26477476 DOI:10.1016/j.surg.2015.09.003]
148 Lee H,Choi SH,Cho YB,Yun SH,Kim HC,Lee WY,Heo JS,Choi DW,Jung KU,Chun HK.Repeat hepatic resection in patients with colorectal liver metastases.World J Gastroenterol 2015;21:2124-2130[PMID:25717247 DOI:10.3748/wjg.v21.i7.2124]
149 Luo LX,Yu ZY,Huang JW,Wu H.Selecting patients for a second hepatectomy for colorectal metastases:an systemic review and meta-analysis.Eur J Surg Oncol 2014;40:1036-1048[PMID:24915859 DOI:10.1016/j.ejso.2014.03.012]
150 Martínez-Cecilia D,Cipriani F,Vishal S,Ratti F,Tranchart H,Barkhatov L,Tomassini F,Montalti R,Halls M,Troisi RI,Dagher I,Aldrighetti L,Edwin B,Abu Hilal M.Laparoscopic Versus Open Liver Resection for Colorectal Metastases in Elderly and Octogenarian Patients:A Multicenter Propensity Score Based Analysis of Short-and Long-term Outcomes.Ann Surg 2017;265:1192-1200[PMID:28151797 DOI:10.1097/SLA.0000000000002147]
151 Nardo B,Serafini S,Ruggiero M,Grande R,Fugetto F,Zullo A,Novello M,Rizzuto A,Bonaiuto E,Vaccarisi S,Cavallari G,Serra R,CannistràM,Sacco R.Liver resection for metastases from colorectal cancer in very elderly patients:New surgical horizons.Int J Surg 2016;33 Suppl 1:S135-S141[PMID:27353843 DOI:10.1016/j.ijsu.2016.06.014]
152 van Tuil T,Dhaif AA,Te Riele WW,van Ramshorst B,van Santvoort HC.Systematic Review and Meta-Analysis of Liver Resection for Colorectal Metastases in Elderly Patients.Dig Surg2018[PMID:29502126 DOI:10.1159/000487274]
153 Leal JN,Sadot E,Gonen M,Lichtman S,Kingham TP,Allen PJ,De Matteo RP,Jarnagin WR,D’Angelica MI.Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians:a contemporary case matched series.HPB(Oxford)2017;19:162-169[PMID:27914765 DOI:10.1016/j.hpb.2016.09.009]
154 De Blasi V,Memeo R,Adam R,GoéréD,Cherqui D,Regimbeau JM,Rivoire M,Perotto LO,Navarro F,Sa Cunha A,Pessaux P;on behalf of the French Colorectal Liver Metastases Working Group,Association Fran?aise de Chirurgie.Major Hepatectomy for Colorectal Liver Metastases in Patients Aged Over 80:APropensity Score Matching Analysis.Dig Surg 2018;35:333-341[PMID:29669343 DOI:10.1159/000486522]
155 M?kel?JT,Klintrup KH,Rautio TT.Mortality and Survival after Surgical Treatment of Colorectal Cancer in Patients Aged over 80Years.Gastrointest Tumors 2017;4:36-44[PMID:29071263 DOI:10.1159/000477721]
156 Xie M,Zhu J,He X,Yang Z,Chen X,Lan P,Lian L.Liver Metastasis from Colorectal Cancer in the Elderly:Is Surgery Justified?Dig Dis Sci 2015;60:3525-3535[PMID:26173502DOI:10.1007/s10620-015-3789-3]
157 Tufo A,Dunne DFJ,Manu N,Joshi H,Lacasia C,Jones L,Malik HZ,Poston GJ,Fenwick SW.Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.Eur JSurg Oncol 2018;44:1040-1047[PMID:29456045 DOI:10.1016/j.ejso.2018.01.089]
158 Yazici P,Akyuz M,Yigitbas H,Dural C,Okoh A,Aydin N,Berber E.A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation.Surg Endosc 2017;31:1269-1274[PMID:27444839 DOI:10.1007/s00464-016-5105-5]
159 Manfredi S,Lepage C,Hatem C,Coatmeur O,Faivre J,Bouvier AM.Epidemiology and management of liver metastases from colorectal cancer.Ann Surg 2006;244:254-259[PMID:16858188DOI:10.1097/01.SLA.0000217629.94941.cf]
160 van der Geest LG,Lam-Boer J,Koopman M,Verhoef C,Elferink MA,de Wilt JH.Nationwide trends in incidence,treatment and survival of colorectal cancer patients with synchronous metastases.Clin Exp Metastasis 2015;32:457-465[PMID:25899064 DOI:10.1007/s10585-015-9719-0]
161 Scheele J,Altendorf-Hofmann A.Resection of colorectal liver metastases.Langenbecks Arch Surg 1999;384:313-327[PMID:10473851 DOI:10.1007/s004230050209]
162 Luo D,Liu Q,Yu W,Ma Y,Zhu J,Lian P,Cai S,Li Q,Li X.Prognostic value of distant metastasis sites and surgery in stage IVcolorectal cancer:a population-based study.Int J Colorectal Dis2018;33:1241-1249[PMID:29931408 DOI:10.1007/s00384-018-3091-x]
163 Leung U,G?nen M,Allen PJ,Kingham TP,DeMatteo RP,Jarnagin WR,D'Angelica MI.Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.Ann Surg 2017;265:158-165[PMID:28009741 DOI:10.1097/SLA.0000000000001624]
164 Imai K,Castro Benitez C,Allard MA,Vibert E,Sa Cunha A,Cherqui D,Castaing D,Bismuth H,Baba H,Adam R.Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.J Surg Oncol 2017;115:488-496[PMID:28369939 DOI:10.1002/jso.24539]
165 Hadden WJ,de Reuver PR,Brown K,Mittal A,Samra JS,Hugh TJ.Resection of colorectal liver metastases and extra-hepatic disease:a systematic review and proportional meta-analysis of survival outcomes.HPB(Oxford)2016;18:209-220[PMID:27017160 DOI:10.1016/j.hpb.2015.12.004]
166 Okuno M,Goumard C,Mizuno T,Kopetz S,Omichi K,Tzeng CD,Chun YS,Lee JE,Vauthey JN,Conrad C.Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.Br J Surg 2018;105:1200-1209[PMID:29664996 DOI:10.1002/bjs.10822]
167 Ferrarotto R,Pathak P,Maru D,Agarwal A,Overman M,Hoff PM,Kopetz S.Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.Clin Colorectal Cancer 2011;10:178-182[PMID:21855039 DOI:10.1016/j.clcc.2011.03.023]
168 Chua TC,Saxena A,Liauw W,Chu F,Morris DL.Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review.Eur J Cancer 2012;48:1757-1765[PMID:22153217 DOI:10.1016/j.ejca.2011.10.034]
169 Adam R,de Haas RJ,Wicherts DA,Vibert E,Salloum C,Azoulay D,Castaing D.Concomitant extrahepatic disease in patients with colorectal liver metastases:when is there a place for surgery?Ann Surg 2011;253:349-359[PMID:21178761 DOI:10.1097/SLA.0b013e318207bf2c]
